Health Care Checkup

June 26, 2026

THE BIG PICTURE: KEY CONGRESSIONAL & EXECUTIVE BRANCH DEVELOPMENTS


On Thursday, the House Energy and Commerce Health Subcommittee held a markup and advanced 15 health care and public health bills aimed at improving hospital and insurer price transparency and combating illicit drugs. All the bills advanced by voice vote.


On Thursday, the House Education and Workforce Committee held a markup of 11 bills, advancing all of them, including four health care bills that would expand group health plan access to de-identified claims and pricing data, allow suspension of payments to providers convicted of health care fraud, require the FBI to provide criminal history records for state licensing background checks under interstate compacts, and allow nurse practitioners and physician assistants to order certain services and supplies for eligible energy workers.


On Thursday, President Trump nominated Chris Klomp to serve as deputy secretary of Health and Human Services (HHS). Klomp currently serves as both the Senior Advisor to HHS Secretary Robert F. Kennedy Jr and the Director of Medicare and Deputy Administrator at the Centers for Medicare and Medicaid Services.


On Monday, the Department of Health and Human Services (HHS) announced a department-wide effort to strengthen U.S. leadership in clinical research, bring more early-stage trials back to the U.S., and accelerate patient access to innovative treatments.

What to Expect Next Week:



In the House, on Wednesday, the Education and Workforce Subcommittee on Health, Employment, Labor, and Pensions will hold a hearing titled, “Direct Contracting: A Prescription for Lower Health Care Costs.”


The Senate will be in recess for the next two weeks and will return to session on Monday, July 13. 

DEEP DIVE

Congressional:



House Energy and Commerce Health Subcommittee Committee Holds Markup of 15 Health Care Bills

On Thursday, the House Energy and Commerce Health Subcommittee held a markup and advanced 15 health care and public health bills aimed at improving hospital and insurer price transparency and combating illicit drugs. All the bills advanced by voice vote:  

  • H.R. 1266, Combatting Illicit Xylazine Act (Reps. Panetta and Pfluger) – Would add xylazine to Schedule III of the Controlled Substances Act and modify regulations regarding its use and tracking.
  • H.R. 2004, Tyler’s Law (Reps. Lieu and Latta) – Would direct the Department of Health and Human Services (HHS) to study and issue guidance on routine fentanyl testing in hospital emergency departments for overdose patients.
  • H.R. 7970, STOP Nitazenes Act (Rep. Latta) – Would permanently classify dangerous nitazene synthetic opioids as Schedule I Controlled substances.
  • H.R. 1561, ALERT Communities Act (Reps. Crockett and Gooden) – Would amend the Public Health Service Act to authorize grants for first responders to access and train on fentanyl and xylazine test strips.
  • H.R. 7994, HERO Act (Rep. Ruiz) – Would establish grants for schools to obtain opioid overdose reversal drugs and require reporting of their distribution.
  • H.R. 9389, Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026 (Rep. Harshbarger) – Would authorize funding for nutrition education and chronic disease prevention at federally qualified health centers.
  • H.R. 8201, Expanding Community Access to Health Services Act (Rep. Lee-NV) – Would provide $700 million in annual funding for community health centers to provide behavioral, mental health, and substance use disorder services.
  • H.R. 9393, Lower Costs, More Transparency Act of 2026 (Reps. Guthrie and Pallone) – Would mandate that hospitals publicly disclose prices and charges for services to increase healthcare cost transparency.
  • H.R. 9397, Premium Transparency Act (Reps. Pfluger and Moran) – Would require health insurers to publish overhead costs and claim payments.
  • H.R. 9396, Prior Authorization Accountability Act (Rep. Goldman-TX) – Would require health insurers to publicly disclose detailed information about their prior authorization practices.
  • H.R. 9390, Prices on the Wall Act of 2026 (Rep. Miller-Meeks) – Would require certain facilities to post prices on the walls.
  • H.R. 3514, Improving Seniors’ Timely Access to Care Act of 2025 (Reps. Kelly and DelBene) – Would establish requirements for Medicare Advantage plans regarding prior authorization, including electronic transmission, transparency, and enrollee protection.
  • H.R. 9392, Medicare Advantage Cost Transparency Act (Reps. DeGette and Joyce-PA) – Would require Medicare Advantage plans to disclose beneficiary cost-sharing and the source of health risk assessments in their data submissions.
  • H.R. 5243, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. (Rep. McClellan) – Would require Medicare Advantage organizations to report enrollee-level data on supplemental benefits to the HHS Secretary starting in 2029.
  • H.R. 9395, Transparency in Medicare Advantage Steering Act (Rep. Ocasio-Cortez) – Would require Medicare Advantage organizations to report agent/broker compensation and enrollment data to increase transparency.

 

House Education and Workforce Committee Holds Markup and Advances Four Health Care Bills

On Thursday, the House Education and Workforce Committee held a markup of 11 bills, advancing all of them, including four health care bills:

  • H.R. 9228, Health Data Access, Transparency, and Affordability Act of 2026: (Agreed to by Roll Call Vote, 18-15) – Would grant group health plans greater access to de-identified claims and pricing terms from network providers, with penalties for non-compliance.
  • H.R. 8823, Putting Patients First by Strengthening Provider Accountability in FECA Act: (Agreed to by Roll Call Vote, 33-0) – Would grant the Secretary of Labor the authority to suspend payments to medical providers who have been convicted of fraud in federal or state health programs.
  • H.R. 2332, States Handling Access to Reciprocity for Employment (SHARE) Act of 2025: (Agreed to by Roll Call Vote, 33-0) – Would require the FBI to provide criminal history records to state licensing authorities for professional license background checks required by interstate compacts.
  • H.R. 4122, Health Care for Energy Workers Act of 2025: (Agreed to by Roll Call Vote, 18-15)  – Would allow nurse practitioners and physician assistants, acting within their state's scope of practice and following presidential regulations, to prescribe, recommend, or order necessary services, appliances, and supplies for individuals receiving medical benefits for illnesses under the program.

 

House Energy and Commerce O&I Subcommittee Holds Hearing on State Medicaid Program Integrity

On Thursday, the House Energy and Commerce Oversight and Investigations Subcommittee held a hearing to examine state Medicaid fraud. Witnesses included Medicaid directors from Minnesota, Ohio, New York, and California. During the hearing, Republicans emphasized that Medicaid fraud is rampant, particularly in home and community-based services (HCBS), hospice, and autism programs, and that the Centers for Medicare and Medicaid Services (CMS) funding deferrals were necessary accountability measures to protect taxpayers and vulnerable patients. Democrats argued that the Trump administration is using fraud allegations to indiscriminately cut Medicaid funding to blue states as political retribution. State Medicaid directors detailed their program integrity investments, including enhanced provider screening, data analytics, and multidisciplinary investigations. Witnesses from Minnesota, California, and New York expressed concern over CMS funding deferrals and a lack of federal collaboration, while Ohio's director highlighted a cooperative federal-state partnership. Read the witness testimonies here. 


Notable Bills:


Senate HELP Chairman Cassidy Releases 340B Drug Pricing Program Discussion Draft

On Thursday, Senator Bill Cassidy, M.D. (R-LA), Chairman of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee, released a legislative discussion draft on the 340B Drug Pricing Program. The 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act) discussion draft aims to strengthen oversight and accountability in the 340B program by preventing duplicate discounts, clarifying key definitions, increasing transparency around 340B revenue, and closing eligibility loopholes. It also seeks to protect low-income patients, limit predatory practices by middlemen and contract pharmacies, and reform the Prime Vendor Program to improve access, choice, and competition. Cassidy is asking for stakeholder feedback on his proposal by August 28, 2026. Read the press release here, the discussion draft here, the section-by-section summary here, and the one-pager here. 

 

Senate HELP Committee Issues Request for Final Stakeholder Feedback on the Patients Deserve Price Tags Act

On Thursday, the Senate Health, Education, Labor and Pensions (HELP) Committee requested a final round of stakeholder feedback on S. 2355, the Patients Deserve Price Tags Act, as the Committee prepares to move the legislation toward markup. Feedback must be submitted in writing, either through comments or a redline. All feedback is due no later than Thursday, July 2, at 5:00 p.m. ET. Read the redline comparing the current working draft to the introduced version of the legislation here and the clean copy of the current working draft here.

 

Senators Blunt Rochester, Wyden, Schumer Lead Legislation to Cap Medicare Costs for Seniors

On Thursday, Senator Lisa Blunt Rochester (D-DE), Senate Finance Committee Ranking Member Ron Wyden (D-OR), and Senate Democratic Leader Chuck Schumer (D-NY) introduced the Medicare Cost Cap Act. The legislation would cap out-of-pocket costs at $5,000 for Traditional Medicare (Parts A and B) beneficiaries. Currently, Traditional Medicare does not have an annual limit on out-of-pocket costs, whereas Medicare Advantage (MA), employer-sponsored insurance, and insurance purchased through the marketplace all have annual caps on out-of-pocket spending. Read the press release here and the bill here.

 

Senators Hawley and Hassan Introduce Legislation to Fund Rural Hospitals, Ensure Access to Emergency Care

On Wednesday, Senators Josh Hawley (R-MO) and Maggie Hassan (D-NH) introduced the Rural Hospital Emergency Room Guarantee Act. The legislation would create a dedicated 10-year funding stream to help keep rural emergency rooms open, including a baseline annual payment of $1 million for eligible rural hospitals and additional funding based on geographic, patient, and financial factors. It would also allow one-time emergency payments of up to $250,000 for participating hospitals at risk of immediate closure without affecting their eligibility for other federal health care programs, grants, or funding. Read the press release here and the bill here.

 

Senators Young, Bennet Introduce PASTEUR Act to Fight Antimicrobial Resistance

On Wednesday, Senators Todd Young (R-IN), Michael Bennet (D-CO), Kirsten Gillibrand (D-NY), Mike Rounds (R-SD), and John Hickenlooper (D-CO) introduced the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act to encourage innovative drug development targeting the most threatening infections, improve the appropriate use of antibiotics and antifungals, and ensure domestic availability of critical antibiotics when needed. The legislation would establish a subscription-style model, which would offer antibiotic developers predictable payments in exchange for access to their antibiotics. Read the press release here and the bill here.

 

Representatives Bilirakis, Arrington, Miller-Meeks, Cammack, Palmer, Allen, Bean, and Carter Introduce Bill to Strengthen Medicaid Oversight

On Wednesday, Representatives Gus Bilirakis (R-FL), Jodey Arrington (R-TX), Mariannette Miller-Meeks (R-IA), Kat Cammack (R-FL), Gary Palmer (R-AL), Rick Allen (R-GA), Aaron Bean (R-FL), and Buddy Carter (R-GA) introduced the Medicaid RAC Improvement Act of 2026. The legislation would implement key recommendations from the Government Accountability Office (GAO), strengthen reporting requirements for Medicaid Recovery Audit Contractors (RACs) programs, increase transparency and accountability across states, expand oversight of managed care payments, and modernize payment integrity efforts. Companion legislation is being introduced in the Senate by Senator Rick Scott (R-FL). Read the press release here and the bill here. 


Executive Branch:


President Trump Nominates Chris Klomp to be HHS Deputy Secretary

On Thursday, President Trump nominated Chris Klomp to serve as deputy secretary of Health and Human Services (HHS). The deputy secretary position has been vacant since Jim O’Neill departed the post in February. Klomp currently serves as both the Senior Advisor to HHS Secretary Robert F. Kennedy Jr and the Director of Medicare and Deputy Administrator at the Centers for Medicare and Medicaid Services. Trump announced the nomination of Truth Social, stating, "Everywhere Chris goes, he earns TRUST. He is a person of principle, and is deeply committed to serving the AMERICAN People — and fixing our broken Healthcare System.”

 

HHS Launches Department-Wide Effort to Restore American Leadership in Clinical Trials

On Monday, the Department of Health and Human Services (HHS) announced a department-wide effort to strengthen U.S. leadership in clinical research, bring more early-stage trials back to the U.S., and accelerate patient access to innovative treatments. The initiative includes actions by the Food and Drug Administration (FDA), National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), National Cancer Institute (NCI), Office of the National Coordinator for Health Information Technology (ONC), Advanced Research Projects Agency for Health (ARPA-H), and HHS Office of Inspector General (OIG) to reduce delays, clarify regulatory expectations, improve clinical trial design and enrollment, expand the use of artificial intelligence (AI), connect patients with trial opportunities, and modernize research tools. The efforts are intended to strengthen domestic research capacity, streamline clinical trial processes, increase patient participation, and ensure that future medical breakthroughs are developed in the U.S. Read the press release here and the roadmap here.

 

CMS Releases Calendar Year (CY) 2027 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule

On Wednesday, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule to update payment rates and policies under the ESRD Prospective Payment System (PPS) for renal dialysis services furnished to Medicare beneficiaries on or after Jan. 1, 2027. The rule also proposes updates to the acute kidney injury (AKI) dialysis payment rate for renal dialysis services furnished by ESRD facilities for calendar year (CY) 2027 and proposes to update requirements for the ESRD Quality Incentive Program (QIP). For CY 2027, CMS proposes to increase the ESRD PPS base rate to $299.55, which it estimates would raise total Medicare payments to freestanding and hospital-based dialysis facilities by about 1.1 percent and incorporate phosphate binders into the base rate. Read the fact sheet here and the proposed rule here.

CONGRESSIONAL HEARINGS & EVENTS

House:  


House Education and Workforce Committee, Subcommittee on Health, Employment, Labor, and Pensions – Hearing

“Direct Contracting: A Prescription for Lower Health Care Costs.”

Wednesday, July 1, at 10:15 AM



Senate: The Senate will be in recess for the next two weeks and will return to session on Monday, July 13. 

ADMINISTRATION ANNOUNCEMENTS

Centers for Medicare & Medicaid Services

Food and Drug Administration

National Institutes of Health

1341 G Street NW
Washington, DC 20005
202-585-0258